Description
A p300/CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cells; reduces proliferation of various tumor cell lines; inhibits expression of PSA and H3K27Ac occupancy at the PSA enhancer in LNCaP-FGC cells; reduces tumor volume in a LuCaP-77 mouse xenograft model of castration-resistant prostate cancer at 100 mg twice per day for 21 days
Formal name: (1R)-N-[(4-fluorophenyl)methyl]-2,3-dihydro-5-[[(methylamino)carbonyl]amino]-2′,4′-dioxo-N-[(1S)-2,2,2-trifluoro-1-methylethyl]-spiro[1H-indene-1,5′-oxazolidine]-3′-acetamide
Synonyms:
Molecular weight: 536.5
CAS: 1889279-16-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Acetyltransferases||Research Area